Approval · Notice of Compliance 17179 · 2015
JETREA: Notice of Compliance 17179
Issued August 10, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17179
- Date
- August 10, 2015
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site
- Therapeutic class
- Ophthalmoilogical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JETREA | Not yet assigned | — |
Medicinal ingredients
- OCRIPLASMIN 2.5 MG per ML